Page last updated: 2024-12-11

isorhapontigenin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

isorhapontigenin: isolated from the seeds of Aiphanes aculeata Willd. (Arecaceae); structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Aiphanesgenus[no description available]ArecaceaeThe palm family of order Arecales, subclass Arecidae, class Liliopsida.[MeSH]
Aiphanes aculeataspecies[no description available]ArecaceaeThe palm family of order Arecales, subclass Arecidae, class Liliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID5318650
CHEMBL ID110370
CHEBI ID167830
SCHEMBL ID13004148
SCHEMBL ID14782177
MeSH IDM0395189

Synonyms (42)

Synonym
AC-7023
32507-66-7
CHEBI:167830
5-[(e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]benzene-1,3-diol
MEGXP0_001015
ACON1_000713
3'-methoxy-resveratrol
NCGC00169431-01
isorhapontigenin
CHEMBL110370
3,4',5-trihydroxy-3'-methoxy-trans-stilbene
I0804
(e)-5-(4-hydroxy-3-methoxystyryl)benzene-1,3-diol
A821305
AKOS015915135
5-[(e)-2-(4-hydroxy-3-methoxy-phenyl)vinyl]benzene-1,3-diol
SCHEMBL13004148
SCHEMBL14782177
isorhapotogenin
mfcd12407151
3,5,4'-trihydroxy-3'-methoxy-trans-stilbene
ANNNBEZJTNCXHY-NSCUHMNNSA-N
isor
20767-15-1
Q6086299
5-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-1,3-benzenediol
AS-49334
cz49v3k5hs ,
unii-cz49v3k5hs
5-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-1,3-benzenediol
AMY40659
HY-N2593
CS-0022945
1,3-benzenediol, 5-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-
H10554
?isorhapontigenin
1,3-benzenediol, 5-(2-(4-hydroxy-3-methoxyphenyl)ethenyl)-, (e)-
3,4',5-stilbenetriol, 3'-methoxy-, (e)-
1,3-benzenediol, 5-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-
3'-methoxyresveratrol
5-((1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl)-1,3-benzenediol
DTXSID601045304

Research Excerpts

Overview

Isorhapontigenin is a stilbene derivative that has antioxidant, anti‑tumor, and anti‑inflammatory effects. It is an analog of resveratrol and possesses strong antioxidant capacity and cardiovascular-protective effects.

ExcerptReferenceRelevance
"Isorhapontigenin (ISO) is a stilbene derivative that has antioxidant, anti‑tumor, and anti‑inflammatory effects."( Isorhapontigenin prevents β‑amyloid‑associated cognitive impairments through activation of the PI3K/AKT/GSK‑3β pathway.
Gong, F; He, Y; Li, C; Liu, P; Ma, Q; Zhang, W, 2022
)
2.89
"Isorhapontigenin (ISO) is an analog of resveratrol and possesses strong antioxidant capacity and cardiovascular-protective effects."( Isorhapontigenin Attenuates Cardiac Microvascular Injury in Diabetes via the Inhibition of Mitochondria-Associated Ferroptosis Through PRDX2-MFN2-ACSL4 Pathways.
Chen, C; Chen, Y; Chen, Z; Kong, X; Li, S; Li, Y; Qian, J; Sun, K; Yin, M; Zhang, J, 2023
)
3.07
"Isorhapontigenin is a polyphenolic compound found in Chinese herbs and grapes. "( Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
Albadawi, DAI; Chaggar, V; Dash, PR; Patel, K; Patra, PH; Ravishankar, D; Salamah, M; Vaiyapuri, R; Vaiyapuri, S; Watson, KA; Williams, HF, 2019
)
3.4
"Isorhapontigenin is a natural bioactive stilbene isolated from various plants and fruits. "( Isorhapontigenin Improves Diabetes in Mice via Regulating the Activity and Stability of PPARγ in Adipocytes.
Chu, XY; Liu, M; Shi, XC; Wu, JW; Xia, B; Yang, SZ; Yuan, Y; Zhang, DY; Zhu, MQ, 2020
)
3.44
"Isorhapontigenin (ISO) is a new derivative of stilbene compound that was isolated from the Chinese herb Gnetum Cleistostachyum and has been used for treatment of bladder cancers for centuries. "( Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells.
Cao, Z; Fang, Y; Hou, Q; Huang, C; Li, J; Ma, C; Wu, XR; Yao, C, 2013
)
2.07
"Isorhapontigenin (ISO) is a new derivative of stilbene isolated from the Chinese herb Gnetum cleistostachyum. "( SESN2/sestrin 2 induction-mediated autophagy and inhibitory effect of isorhapontigenin (ISO) on human bladder cancers.
Huang, C; Huang, H; Jiang, G; Jin, H; Li, J; Li, Y; Liang, Y; Liu, Z; Wang, Y; Xiang, D; Zhang, D; Zhu, J, 2016
)
2.11
"Isorhapontigenin is a derivative of stilbene with chemical structure similar to resveratrol."( Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats.
Abbas, AM, 2016
)
1.41

Effects

ExcerptReferenceRelevance
"Isorhapontigenin (ISO) has been shown to have antioxidant activity. "( Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO-1 signaling pathway.
Kong, D; Sun, Z; Wu, C; Xu, B; Xue, Z; Yu, B; Zhao, K, 2021
)
3.51

Pharmacokinetics

ExcerptReferenceRelevance
" The purpose of this study is to investigate the pharmacokinetic of ISO in mice plasma, after oral administration of three doses (40, 80, and 160 mg/kg)."( Plasma pharmacokinetics of isorhapontigenin, a novel derivative of stilbenes, in mice by LC-MS/MS method.
Jin, B; Li, T; Ma, C; Wang, YL; Zhang, TT, 2019
)
0.81

Bioavailability

Isorhapontigenin possesses greater oral bioavailability than resveratrol. It has also been identified to possess anti-cancer and anti-inflammatory properties.

ExcerptReferenceRelevance
"Isorhapontigenin, an orally bioavailable dietary polyphenol, displayed superior anti-inflammatory effects compared with resveratrol."( Isorhapontigenin, a bioavailable dietary polyphenol, suppresses airway epithelial cell inflammation through a corticosteroid-independent mechanism.
Barnes, PJ; Donnelly, LE; Fenwick, PS; Lin, HS; Yeo, SCM, 2017
)
3.34
" Isorhapontigenin possesses greater oral bioavailability than resveratrol and has also been identified to possess anti-cancer and anti-inflammatory properties."( Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
Albadawi, DAI; Chaggar, V; Dash, PR; Patel, K; Patra, PH; Ravishankar, D; Salamah, M; Vaiyapuri, R; Vaiyapuri, S; Watson, KA; Williams, HF, 2019
)
2.87
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
stilbenoidAny olefinic compound characterised by a 1,2-diphenylethylene backbone.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1059139Antiproliferative activity against human A2780 cells after 2 days by Alamar Blue assay2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Bioactive compounds from Stuhlmannia moavi from the Madagascar dry forest.
AID132501Inhibitory activity against nitric oxide production in LPS-activated mouse peritoneal macrophages2000Bioorganic & medicinal chemistry letters, Feb-21, Volume: 10, Issue:4
Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages.
AID1871467Antiplatelet activity in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP addition and measured after 5 mins
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (1.85)18.2507
2000's9 (16.67)29.6817
2010's27 (50.00)24.3611
2020's17 (31.48)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.03 (24.57)
Research Supply Index4.01 (2.92)
Research Growth Index5.36 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other53 (98.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]